1. Home
  2. MDWD vs FCCO Comparison

MDWD vs FCCO Comparison

Compare MDWD & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • FCCO
  • Stock Information
  • Founded
  • MDWD 2000
  • FCCO 1994
  • Country
  • MDWD Israel
  • FCCO United States
  • Employees
  • MDWD N/A
  • FCCO N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • FCCO Major Banks
  • Sector
  • MDWD Health Care
  • FCCO Finance
  • Exchange
  • MDWD Nasdaq
  • FCCO Nasdaq
  • Market Cap
  • MDWD 179.1M
  • FCCO 166.4M
  • IPO Year
  • MDWD 2014
  • FCCO 1998
  • Fundamental
  • Price
  • MDWD $17.80
  • FCCO $21.31
  • Analyst Decision
  • MDWD Strong Buy
  • FCCO Buy
  • Analyst Count
  • MDWD 1
  • FCCO 1
  • Target Price
  • MDWD $28.00
  • FCCO $21.00
  • AVG Volume (30 Days)
  • MDWD 60.7K
  • FCCO 18.5K
  • Earning Date
  • MDWD 08-14-2024
  • FCCO 10-16-2024
  • Dividend Yield
  • MDWD N/A
  • FCCO 2.81%
  • EPS Growth
  • MDWD N/A
  • FCCO N/A
  • EPS
  • MDWD N/A
  • FCCO 1.42
  • Revenue
  • MDWD $20,141,000.00
  • FCCO $59,227,000.00
  • Revenue This Year
  • MDWD $30.16
  • FCCO N/A
  • Revenue Next Year
  • MDWD $18.44
  • FCCO $9.86
  • P/E Ratio
  • MDWD N/A
  • FCCO $15.04
  • Revenue Growth
  • MDWD N/A
  • FCCO N/A
  • 52 Week Low
  • MDWD $7.45
  • FCCO $15.40
  • 52 Week High
  • MDWD $24.00
  • FCCO $23.30
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 50.02
  • FCCO 52.82
  • Support Level
  • MDWD $16.25
  • FCCO $20.50
  • Resistance Level
  • MDWD $17.90
  • FCCO $22.20
  • Average True Range (ATR)
  • MDWD 0.97
  • FCCO 0.59
  • MACD
  • MDWD -0.05
  • FCCO -0.09
  • Stochastic Oscillator
  • MDWD 36.98
  • FCCO 46.07

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About FCCO First Community Corporation

First Community Corp is a bank holding company, which provides commercial banking services. It is engaged in the general commercial and retail banking business characterized by personalized service and local decision making, emphasizing the banking needs of small to medium-sized businesses, professional concerns, and individuals. It operates through following segments: Commercial and Retail Banking; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate. It offers checking, savings, money market, individual retirement, and certificates of deposit accounts. Its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others.

Share on Social Networks: